BioSpace News Archive

Eli Lilly and Company will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2020.

Hinsdale Orthopaedic Associates, a division of Illinois Bone & Joint Institute, the largest independent, physician-owned orthopedic practice in Illinois, reached a significant milestone this past week by completing their 100th combined hip arthroscopy and periacetabular osteotomy for young adult hip dysplasia.

SK Biopharmaceuticals, Co., Ltd., a global innovative pharmaceutical company, announced plans to initiate a Phase 3 clinical trial for cenobamate in Asia, in line with the company’s planned expansion beyond the U.S., where the drug is approved as a treatment for partial-onset seizures in adults.

Awards support exceptional young researchers to advance the field of lung cancer research

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, today announced the access details for CEO Dwight Egan’s presentation on the Company’s significant growth, profitability, and future objectives at H.C. Wainwright’s 22nd Annual Global Investment Conference

Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that the U.S. Food and Drug Administration (FDA) has added the TODOS 2019-nCoV RT-qPCR Detection Kit to its Notified List under the Emergency Use Authorization program.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 18th Annual Global Healthcare Conference

Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, its chief executive officer, and Robert Ross, M.D., its chief medical officer, will participate in the upcoming H.C. Wainwright Global Healthcare Conference

Eli Lilly and Company (NYSE:LLY) will participate in the Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 17, 2020. Joshua Smiley, senior vice president and Lilly’s chief financial officer, will participate in a virtual fireside chat at 8:40 a.m., Eastern Time.

Adamas Pharmaceuticals, Inc. announced that the compensation committee of the company’s board of directors granted two new employees the option to purchase an aggregate of 269,250 shares of the company’s common stock, at a per share exercise price of $5.12, the closing trading price on September 8, and restricted stock units to acquire 2,125 shares of the company’s common stock.